COM:HARMONYBIOSCIENCES
Harmony Biosciences
- Stock
Last Close
33.23
22/11 21:00
Market Cap
1.90B
Beta: -
Volume Today
487.85K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|
net income | -39.90M - | -151.98M 280.91% | -36.94M 75.69% | 34.60M 193.65% | 181.47M 424.52% | 128.85M 28.99% | |
depreciation and amortization | 184K - | 3.21M 1,644.57% | 10.24M 218.91% | 18.84M 84.04% | 23.39M 24.12% | 24.36M 4.17% | |
deferred income tax | 25.75M - | 26.15M 1.55% | -85.94M 428.70% | -13.42M 84.39% | |||
stock based compensation | 1.08M - | 9.91M 818.35% | 4.69M 52.64% | 15.66M 233.67% | 26.17M 67.14% | 31.70M 21.14% | |
change in working capital | -164K - | 8.29M 5,156.10% | -11.63M 240.23% | 631K 105.43% | -4.11M 750.71% | 35.03M 953.26% | |
accounts receivables | -4.25M - | -17.92M 321.20% | -12.67M 29.32% | -19.90M 57.08% | -19.40M 2.50% | ||
inventory | -1.09M - | -2.73M 151.38% | -609K 77.73% | 135K 122.17% | -1.07M 889.63% | ||
accounts payables | -610K - | 4.90M 902.95% | -3.80M 177.66% | -1.55M 59.12% | 2.79M 279.10% | 8.95M 221.33% | |
other working capital | 446K - | 8.74M 1,858.97% | 12.83M 46.88% | 15.46M 20.49% | 12.87M 16.76% | 46.55M 261.68% | |
other non cash items | 55.13M - | 4.91M 91.10% | 2.68M 45.32% | 3.49M 29.99% | 12.85M 268.42% | ||
net cash provided by operating activities | -38.80M - | -75.44M 94.43% | -2.98M 96.04% | 98.56M 3,401.74% | 144.47M 46.58% | 219.39M 51.86% | |
investments in property plant and equipment | -1.34M - | -127.15M 9,374.59% | -2.00M 98.43% | -100.30M 4,909.89% | -40.17M 59.95% | -312K 99.22% | |
acquisitions net | -52M - | -2M 96.15% | -100M 4,900% | 141.83M 241.83% | -36.97M 126.06% | ||
purchases of investments | -110.73M - | -127.47M 15.12% | |||||
sales maturities of investments | 9.07M - | 118.31M 1,204.54% | |||||
other investing activites | 52M - | 2M 96.15% | 100M 4,900% | -141.83M 241.83% | |||
net cash used for investing activites | -1.34M - | -127.15M 9,374.59% | -2.00M 98.43% | -100.30M 4,909.89% | -141.83M 41.41% | -46.44M 67.26% | |
debt repayment | -94.82M - | -120.58M 27.18% | -222.50M 84.52% | -2M 99.10% | -201.25M 9,962.50% | ||
common stock issued | 50.09M - | 147.63M 194.75% | 30M 79.68% | 8.84M 70.53% | 5.05M 42.82% | ||
common stock repurchased | -3.20M - | -1.13M 64.63% | -167K 85.25% | -100M - | |||
dividends paid | -143.77M - | -200.30M 39.32% | -5.05M - | ||||
other financing activites | 24.82M - | 333.40M 1,243.55% | 382.58M 14.75% | 199.92M 47.75% | 195.70M - | ||
net cash used provided by financing activities | 21.61M - | 143.77M 565.14% | 209.16M 45.48% | 7.42M 96.45% | 6.84M 7.79% | -105.55M 1,642.93% | |
effect of forex changes on cash | |||||||
net change in cash | -18.53M - | -58.82M 217.48% | 204.17M 447.14% | 5.68M 97.22% | 9.47M 66.87% | 67.40M 611.30% | |
cash at beginning of period | 102.55M - | 84.02M 18.07% | 25.21M 70.00% | 229.38M 809.99% | 235.06M 2.48% | 244.53M 4.03% | |
cash at end of period | 84.02M - | 25.21M 70.00% | 229.38M 809.99% | 235.06M 2.48% | 244.53M 4.03% | 311.93M 27.56% | |
operating cash flow | -38.80M - | -75.44M 94.43% | -2.98M 96.04% | 98.56M 3,401.74% | 144.47M 46.58% | 219.39M 51.86% | |
capital expenditure | -1.34M - | -127.15M 9,374.59% | -2.00M 98.43% | -100.30M 4,909.89% | -40.17M 59.95% | -312K 99.22% | |
free cash flow | -40.14M - | -202.59M 404.68% | -4.99M 97.54% | -1.74M 65.09% | 104.29M 6,090.47% | 219.07M 110.06% |
All numbers in (except ratios and percentages)